KELSIE COURT: Open Payments
NPI 1982128716 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 22 payments from 13 companies in 2025. Trend: 2023 $561 · 2024 $361 · 2025 $400
Food & beverage: $400
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $141 |
| Viatris Specialty LLC | 2 | $38 |
| Exact Sciences Corporation | 2 | $33 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| SANOFI-AVENTIS U.S. LLC | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
Products named: Rybelsus, YUPELRI, Ozempic, SHINGRIX, Wegovy, TZIELD, VRAYLAR, Kerendia.
Industry payments across TX — which companies pay providers there.
